Original Research

Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan

Watanabe Y, Asami Y, Hirano Y, Kuribayashi K, Itamura R, Imaeda T

Neuropsychiatric Disease and Treatment 2018, 14:1261-1272

Published Date: 16 May 2018